tiprankstipranks
Trending News
More News >
Pharma Mar SA (PHMMF)
OTHER OTC:PHMMF
US Market

Pharma Mar SA (PHMMF) Income Statement

Compare
51 Followers

Pharma Mar SA Income Statement

Last quarter (Q1 2025), Pharma Mar SA's total revenue was €38.86M, an increase of 2.35% from the same quarter last year. In Q1, Pharma Mar SA's net income was €-3.95M. See Pharma Mar SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 174.85M€ 158.15M€ 196.34M€ 229.83M€ 269.96M
Gross Profit
€ 166.67M€ 148.54M€ 182.70M€ 213.39M€ 256.24M
Operating Expenses
€ 160.20M€ 152.37M€ 138.27M€ 121.04M€ 100.03M
Depreciation and Amortization
€ 6.77M€ 5.76M€ 5.90M€ 5.58M€ 7.21M
EBITDA
€ 21.23M€ 4.55M€ 52.07M€ 104.08M€ 155.94M
Operating Income
€ 6.47M€ -3.83M€ 44.07M€ 92.45M€ 155.94M
Other Income/Expenses
€ 5.52M€ 204.00K€ -281.00K€ -6.36M€ -10.34M
Pretax Income
€ 11.98M€ -3.62M€ 43.79M€ 95.13M€ 145.61M
Net Income
€ 26.13M€ 1.14M€ 49.36M€ 92.86M€ 137.26M
Per Share Metrics
Basic EPS
€ 1.48€ 0.06€ 2.73€ 5.14€ 7.50
Diluted EPS
€ 1.48€ 0.06€ 2.73€ 5.13€ 7.49
Weighted Average Shares Outstanding
17.54M 17.90M 18.05M 18.07M 18.29M
Weighted Average Shares Outstanding (Diluted)
17.56M 17.92M 18.06M 18.09M 18.32M
Currency in EUR

Pharma Mar SA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis